PNC Financial Services Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
CG
BIM
RCM
TCM
HJMC
PNC Financial Services Group's LABU Position: Q4 2021 in Review
PNC Financial Services Group sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2021, closing a stake of 5 shares — an estimated $6K sold.
PNC Financial Services Group first reported a position in LABU in Q4 2018 and held it in 10 quarters. The position peaked at $64K in Q3 2020. 33 funds tracked by Wall St. Rank hold LABU as of Q4 2021.
- PNC Financial Services Group reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2021 after selling out during the quarter.
- PNC Financial Services Group sold 5 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2021, an estimated $6K.
- PNC Financial Services Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 10 quarters.
- PNC Financial Services Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $64K in Q3 2020.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2021.
Based on PNC Financial Services Group's 13F filing for Q4 2021, filed 11 Feb 2022.